602 related articles for article (PubMed ID: 17167242)
1. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
Navarro JF; Milena FJ; Mora C; León C; García J
Am J Nephrol; 2006; 26(6):562-70. PubMed ID: 17167242
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
[TBL] [Abstract][Full Text] [Related]
3. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
[TBL] [Abstract][Full Text] [Related]
4. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats.
DiPetrillo K; Gesek FA
Am J Nephrol; 2004; 24(3):352-9. PubMed ID: 15205554
[TBL] [Abstract][Full Text] [Related]
6. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial.
Navarro JF; Mora C; Muros M; García J
J Am Soc Nephrol; 2005 Jul; 16(7):2119-26. PubMed ID: 15917336
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes.
Zhang X; Li ZZ; Liu DF; Xu X; Mei ZC; Shen W
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):631-6. PubMed ID: 19076162
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy.
Navarro-González JF; Jarque A; Muros M; Mora C; García J
Cytokine Growth Factor Rev; 2009 Apr; 20(2):165-73. PubMed ID: 19251467
[TBL] [Abstract][Full Text] [Related]
9. Pro-inflammatory cytokines and interleukin 6 in the renal response to bacterial endotoxin.
Kayama F; Yoshida T; Kodama Y; Matsui T; Matheson JM; Luster MI
Cytokine; 1997 Sep; 9(9):688-95. PubMed ID: 9325018
[TBL] [Abstract][Full Text] [Related]
10. Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats.
Nielsen B; Grønbaek H; Osterby R; Flyvbjerg A
Exp Diabesity Res; 2003; 4(3):191-9. PubMed ID: 15061647
[TBL] [Abstract][Full Text] [Related]
11. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the temporal profile of expression and release of major pro-inflammatory cytokines in vital organs following hemorrhagic shock].
Liu YJ; Mao EQ; Li L; Tang YQ; Zhang SD
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 May; 19(5):290-4. PubMed ID: 17490570
[TBL] [Abstract][Full Text] [Related]
13. Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes.
DiPetrillo K; Coutermarsh B; Gesek FA
Am J Physiol Renal Physiol; 2003 Jan; 284(1):F113-21. PubMed ID: 12388406
[TBL] [Abstract][Full Text] [Related]
14. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury.
He J; Evans CO; Hoffman SW; Oyesiku NM; Stein DG
Exp Neurol; 2004 Oct; 189(2):404-12. PubMed ID: 15380490
[TBL] [Abstract][Full Text] [Related]
15. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy.
Thallas-Bonke V; Coughlan MT; Bach LA; Cooper ME; Forbes JM
Am J Nephrol; 2010; 32(1):73-82. PubMed ID: 20551625
[TBL] [Abstract][Full Text] [Related]
16. Early increase in mRNA levels of pro-inflammatory cytokines and their interactions in the mouse hippocampus after transient global ischemia.
Zhu Y; Saito K; Murakami Y; Asano M; Iwakura Y; Seishima M
Neurosci Lett; 2006 Jan; 393(2-3):122-6. PubMed ID: 16356636
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin inhibits pro-inflammatory cytokine secretion from rat hepatic stellate cells.
Lang A; Sakhnini E; Fidder HH; Maor Y; Bar-Meir S; Chowers Y
Liver Int; 2005 Aug; 25(4):808-16. PubMed ID: 15998432
[TBL] [Abstract][Full Text] [Related]
18. [Pentoxifylline old drug or new hope for nephrology?].
Renke M; Rutkowski P; Tylicki L; Zietkiewicz M; Larczyński W; Rutkowski B
Przegl Lek; 2008; 65(7-8):358-61. PubMed ID: 19004236
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
Zheng M; Ye S; Zhai Z; Chen Y; Li X; Yang G; Fan A; Wang Y
J Diabetes Complications; 2009; 23(2):124-9. PubMed ID: 18413206
[TBL] [Abstract][Full Text] [Related]
20. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy.
Wu CC; Chen JS; Lu KC; Chen CC; Lin SH; Chu P; Sytwu HK; Lin YF
Clin Chim Acta; 2010 May; 411(9-10):700-4. PubMed ID: 20138168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
